Category Regulatory

Libra Therapeutics, Inc., a private biotechnology company pioneering novel disease-modifying therapeutics designed to restore cellular homeostasis and slow the progression of neurodegenerative diseases, today announced the promotion of Martin (Marty) Gill, Ph.D., to Chief Scientific Officer (CSO). Dr. Gill, who…

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the establishment of a global, cross-functional Scientific Advisory Board to guide the company’s strategic focus on New Approach Methodologies (NAMs). The Advisory Board, led by Dr. Namandjé N. Bumpus, will play…

MindWalk Holdings Corp.™, a Bio-Native AI company transforming life sciences data intelligence, today announced the appointment of industry veteran Thomas W. Lynch, Ph.D., as Chief Business Officer (CBO), effective October 20, 2025. This strategic hire is aimed at accelerating the…

Orum Therapeutics, a public biotechnology company pioneering the development of degrader–antibody conjugates (DACs), has announced the appointment of Dorin Toader, Ph.D., as Head of Platform Technology. With over 27 years of experience in drug discovery and more than 15 years…

Farmland LP, the largest U.S. manager exclusively focused on organic and regenerative farmland, together with Carbon Friendly, a leading developer of regenerative carbon projects, have achieved a major milestone in the voluntary carbon market. The two organizations have submitted the…

Deep Genomics, the AI-first TechBio company pioneering next-generation genomic medicines through its advanced AI foundation model platform, today announced the appointment of Thong Q. Le and Paul Sekhri to its Board of Directors. These appointments strengthen Deep Genomics’ leadership as…

Pilatus Biosciences Inc., a biopharmaceutical company pioneering metabolic checkpoint immunotherapies for liver and gastrointestinal cancers, announced the issuance of its foundational patent in Europe and Australia titled “Methods for Modulating Regulatory T Cells and Inhibiting Tumor Growth.” This milestone marks…

Nurea, a leader in AI-driven medical imaging innovation, has announced that its PRAEVAorta®2 software has received FDA 510(k) clearance, paving the way for its introduction into the U.S. healthcare market. The clearance marks a pivotal step in transforming the way…

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced the appointment of Giovanni Galliano as General Manager for Italy. This appointment marks Avanzanite’s seventh executive leadership hire in 2025, reinforcing its vision…